BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38212751)

  • 21. Combined use of Serum miR-499a-5p and CA199 Increases the Diagnostic Sensitivity of Pancreatic Cancer.
    Shi Q; Feng K; Xia L; Wang C; Zhu J
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
    Li F; Li S; Wei L; Liang X; Zhang H; Liu J
    Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer.
    Su J; Wang Y; Shao H; You X; Li S
    World J Surg Oncol; 2022 Sep; 20(1):323. PubMed ID: 36175918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A preliminary study of retinoblastoma-related serum tumor markers].
    Liu ZP; Zhou KY; Chen LL; Xiao ZH; Chen YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):318-321. PubMed ID: 28302204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum CA50 levels in patients with cancers and other diseases.
    Shan M; Tian Q; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():187-198. PubMed ID: 30905449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy.
    Sun Z; Jia J; Du F; Yang Y; Liu C; Xiao Y; Yu J; Zhang X
    Transl Cancer Res; 2019 Dec; 8(8):2680-2690. PubMed ID: 35117026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of serum human tumor protein P53 in colorectal cancer combined diagnosis and postoperative monitoring].
    Fan P; Zhang Y; Deng F; Chen SH; Li M; Zhang Q
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2670-2673. PubMed ID: 28910954
    [No Abstract]   [Full Text] [Related]  

  • 29. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
    Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
    Tong Y; Zhao Y; Shan Z; Zhang J
    BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma.
    Zhang J; Cao Y; Zhang P; Zhang X; Li J; Zhou J; Wang X; Peng Z; Sun Y; Li J; Shen L; Lu M
    Neuroendocrinology; 2022; 112(8):733-743. PubMed ID: 34592743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of serum CA199 levels with glycemic control and microvascular complications in patients with type 2 diabetes mellitus.
    Tong W; Gao H; Wei X; Mao D; Zhang L; Chen Q; Zhang Z; Li Y
    Am J Transl Res; 2021; 13(4):3302-3308. PubMed ID: 34017502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of diagnostic value of serum Carbohydrate antigen 199 in pancreatic cancer.
    Zhang Y; Jiang L; Song L
    Minerva Med; 2016 Feb; 107(1):62-9. PubMed ID: 26824636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases.
    He Y; Lu H; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():199-212. PubMed ID: 30905450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.
    Lewis JD; Habel LA; Quesenberry CP; Strom BL; Peng T; Hedderson MM; Ehrlich SF; Mamtani R; Bilker W; Vaughn DJ; Nessel L; Van Den Eeden SK; Ferrara A
    JAMA; 2015 Jul; 314(3):265-77. PubMed ID: 26197187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum CA153 as biomarker for cancer and noncancer diseases.
    Li X; Xu Y; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():265-276. PubMed ID: 30905456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.
    Xu WY; Zhang HH; Yang XB; Bai Y; Lin JZ; Long JY; Xiong JP; Zhang JW; Sang XT; Zhao HT
    World J Gastroenterol; 2018 Apr; 24(13):1451-1463. PubMed ID: 29632426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lateral Flow Immunoassay Based on Time-Resolved Fluorescence Microspheres for Rapid and Quantitative Screening CA199 in Human Serum.
    Jiao X; Peng T; Liang Z; Hu Y; Meng B; Zhao Y; Xie J; Gong X; Jiang Y; Fang X; Yu X; Dai X
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis.
    Ding Q; Sun Y; Zhang J; Yao Y; Huang D; Jiang Y
    J Gastrointest Oncol; 2022 Oct; 13(5):2497-2504. PubMed ID: 36388698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.
    Chen J; Wang H; Zhou L; Liu Z; Tan X
    J Clin Lab Anal; 2022 May; 36(5):e24341. PubMed ID: 35334495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.